Tristan Vaughan
33Patents
22h-index
39Co-inventors
85Inventor score
Filing activity: Feb 9, 1996 → Apr 29, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6090382A | Human antibodies that bind human TNF.alpha. | Emerging Cross-Sectional Technologies | 444 | Expired |
| US6258562A | Human antibodies that bind human TNF.alpha. | Emerging Cross-Sectional Technologies | 307 | Expired |
| US6509015B1 | Human antibodies that bind human TNFa | Emerging Cross-Sectional Technologies | 211 | Expired |
| US7223394B2 | Human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 160 | Expired |
| US7541031B2 | Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 147 | Active |
| US7588761B2 | Human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 143 | Expired |
| US7138501B2 | Antibodies that immunospecifically bind BLyS | Chemistry; Metallurgy | 102 | Expired |
| US7348003B2 | Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors | Chemistry; Metallurgy | 90 | Expired |
| US7361341B2 | Methods of treating cancer using antibodies that immunospecifically bind to trail receptors | Chemistry; Metallurgy | 89 | Expired |
| US8414894B2 | Human antibodies that bind human TNFα and methods of using same | Emerging Cross-Sectional Technologies | 73 | Active |
| US8206714B2 | Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa | Emerging Cross-Sectional Technologies | 72 | Active |
| US8197813B2 | Human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 71 | Active |
| US8372401B2 | Human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 70 | Active |
| US8372400B2 | Methods of treating disorders using human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 69 | Active |
| US5994519A | Labelling and selection of molecules | Chemistry; Metallurgy | 56 | Expired |
| US6180336A | Labelling and selection of molecules | Chemistry; Metallurgy | 55 | Expired |
| US6342588B1 | Labelling and selection of molecules | Chemistry; Metallurgy | 51 | Expired |
| US8753633B2 | Human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 49 | Active |
| US6946546B2 | Human antibodies against eotaxin | Chemistry; Metallurgy | 48 | Expired |
| US6489123B2 | Labelling and selection of molecules | Chemistry; Metallurgy | 46 | Expired |
| US7220840B2 | Antibodies that immunospecifically bind to B lymphocyte stimulator protein | Chemistry; Metallurgy | 42 | Expired |
| US7605236B2 | Antibodies that immunospecifically bind to B lymphocyte stimulator protein | Chemistry; Metallurgy | 25 | Active |
| US7879328B2 | Antibodies that immunospecifically bind to B lymphocyte stimulator | Chemistry; Metallurgy | 20 | Active |
| US8101181B2 | Antibodies that immunospecifically bind to B lymphocyte stimulator protein | Chemistry; Metallurgy | 19 | Active |
| US7368111B2 | Human antibodies specific for TGFβ2 | Chemistry; Metallurgy | 17 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.